Cargando…
Determinants of arterial stiffness in COPD
BACKGROUND: Cardiovascular morbidity and mortality is high in patients with chronic obstructive pulmonary disease (COPD) and arterial stiffness is a potentially modifiable risk factor with added predictive value beyond that obtained from traditional risk factors. Arterial stiffness has been the targ...
Autores principales: | Bhatt, Surya P, Cole, Adam G, Wells, James Michael, Nath, Hrudaya, Watts, Jubal R, Cockcroft, John R, Dransfield, Mark T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890490/ https://www.ncbi.nlm.nih.gov/pubmed/24387157 http://dx.doi.org/10.1186/1471-2466-14-1 |
Ejemplares similares
-
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD
por: Bhatt, Surya P, et al.
Publicado: (2017) -
Determinants of successful completion of pulmonary rehabilitation in COPD
por: Brown, Angel T, et al.
Publicado: (2016) -
Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
por: Bhatt, Surya P., et al.
Publicado: (2018) -
Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD
por: Wells, J Michael, et al.
Publicado: (2013) -
Arterial stiffness
por: Quinn, Ursula, et al.
Publicado: (2012)